IT8321352A0 - 3-(3-idrossibutossi)-1-butanolo esuo metodo di preparazione. - Google Patents

3-(3-idrossibutossi)-1-butanolo esuo metodo di preparazione.

Info

Publication number
IT8321352A0
IT8321352A0 IT8321352A IT2135283A IT8321352A0 IT 8321352 A0 IT8321352 A0 IT 8321352A0 IT 8321352 A IT8321352 A IT 8321352A IT 2135283 A IT2135283 A IT 2135283A IT 8321352 A0 IT8321352 A0 IT 8321352A0
Authority
IT
Italy
Prior art keywords
hydroxybutoxy
butanol
preparation
Prior art date
Application number
IT8321352A
Other languages
English (en)
Other versions
IT1164254B (it
IT8321352A1 (it
Inventor
Elso Manghisi
Aldo Salimbeni
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of IT8321352A0 publication Critical patent/IT8321352A0/it
Priority to IT21352/83A priority Critical patent/IT1164254B/it
Priority to US06/603,134 priority patent/US4584321A/en
Priority to GB08411356A priority patent/GB2142623B/en
Priority to ES532802A priority patent/ES8507449A1/es
Priority to JP59108268A priority patent/JPS604146A/ja
Priority to DE19843419947 priority patent/DE3419947A1/de
Priority to FR848408571A priority patent/FR2547813B1/fr
Priority to BE0/213036A priority patent/BE899790A/fr
Publication of IT8321352A1 publication Critical patent/IT8321352A1/it
Application granted granted Critical
Publication of IT1164254B publication Critical patent/IT1164254B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/132—Saturated ethers containing hydroxy or O-metal groups both carbon chains being substituted by hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/164—Unsaturated ethers containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT21352/83A 1983-05-30 1983-05-30 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione IT1164254B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT21352/83A IT1164254B (it) 1983-05-30 1983-05-30 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione
US06/603,134 US4584321A (en) 1983-05-30 1984-04-23 3-(3-Hydroxybutoxy)-1-butanol in pharmaceutical compositions
GB08411356A GB2142623B (en) 1983-05-30 1984-05-03 3-(3-hydroxybutoxy)-1-butanol and its method of preparation
ES532802A ES8507449A1 (es) 1983-05-30 1984-05-25 Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol
JP59108268A JPS604146A (ja) 1983-05-30 1984-05-28 ３−（３−ヒドロキシブトキシ）−１−ブタノ−ルの分離方法
DE19843419947 DE3419947A1 (de) 1983-05-30 1984-05-28 "3-(3-hydroxybutoxy)-1-butanol, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
FR848408571A FR2547813B1 (fr) 1983-05-30 1984-05-30 3-(3-hydroxybutoxy)-1-butanol et sa preparation
BE0/213036A BE899790A (fr) 1983-05-30 1984-05-30 3-(3-hydroxybutoxy)-1-butanol et sa preparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21352/83A IT1164254B (it) 1983-05-30 1983-05-30 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione

Publications (3)

Publication Number Publication Date
IT8321352A0 true IT8321352A0 (it) 1983-05-30
IT8321352A1 IT8321352A1 (it) 1984-11-30
IT1164254B IT1164254B (it) 1987-04-08

Family

ID=11180528

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21352/83A IT1164254B (it) 1983-05-30 1983-05-30 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione

Country Status (8)

Country Link
US (1) US4584321A (it)
JP (1) JPS604146A (it)
BE (1) BE899790A (it)
DE (1) DE3419947A1 (it)
ES (1) ES8507449A1 (it)
FR (1) FR2547813B1 (it)
GB (1) GB2142623B (it)
IT (1) IT1164254B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145712A0 (en) 1999-04-01 2002-07-25 Esperion Therapeutics Inc Ether compounds, compositions, and uses thereof
US6713507B2 (en) 2000-10-11 2004-03-30 Esperion Therapeutics, Inc. Ether compounds and compositions for cholesterol management and related uses
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
AU2002211666A1 (en) 2000-10-11 2002-04-22 Esperion Therapeutics, Inc. Sulfide and disulfide compounds and compositions for cholesterol management and related uses
IL155246A0 (en) 2000-10-11 2003-11-23 Esperion Therapeutics Inc Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
CA2425311C (en) 2000-10-11 2011-06-14 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
EP1495034A2 (en) * 2002-04-10 2005-01-12 Esperion Therapeutics, Inc. Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
CA2513660C (en) * 2003-01-23 2012-05-08 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
WO2005068412A1 (en) 2003-12-24 2005-07-28 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
CN103848726B (zh) * 2012-12-09 2017-09-05 河北凯盛医药科技有限公司 一种高纯度二羟二丁基醚及其制备方法
CN103304383B (zh) * 2013-06-18 2015-04-08 重庆医科大学 保胆健素的新合成方法
CN103319316B (zh) * 2013-06-24 2015-06-10 大连理工大学 一种二羟基二丁醚的绿色制备方法
CN103333057A (zh) * 2013-06-24 2013-10-02 大连理工大学 一种二羟基二丁醚的制备方法
CN104230674A (zh) * 2014-08-28 2014-12-24 成都邦泽生物医药科技有限公司 一种二羟基二丁醚的制备方法
CN107530307A (zh) 2015-03-13 2018-01-02 艾斯柏伦治疗公司 包含etc1002和依泽替米贝的固定剂量组合和制剂以及治疗心血管疾病或降低心血管疾病风险的方法
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
EP4438114A3 (en) 2019-06-21 2024-12-25 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT957008B (it) * 1967-11-09 1973-10-10 Luso Farmaco Inst Processo per la preparazione di eteri simmetrici di glicoli re canti ossidrili primari e secon dari
DE2218935C3 (de) * 1972-04-19 1980-01-31 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von wäßrigen Lösungen von N-Vinylpyrrolidonpolymerisaten

Also Published As

Publication number Publication date
GB2142623A (en) 1985-01-23
US4584321A (en) 1986-04-22
FR2547813A1 (fr) 1984-12-28
ES532802A0 (es) 1985-10-01
BE899790A (fr) 1984-11-30
JPS6241702B2 (it) 1987-09-04
GB8411356D0 (en) 1984-06-06
FR2547813B1 (fr) 1989-01-27
IT1164254B (it) 1987-04-08
DE3419947C2 (it) 1987-11-26
DE3419947A1 (de) 1984-12-06
GB2142623B (en) 1987-04-15
IT8321352A1 (it) 1984-11-30
JPS604146A (ja) 1985-01-10
ES8507449A1 (es) 1985-10-01

Similar Documents

Publication Publication Date Title
FI86251B (fi) Foerfarande foer inkapsling av en svagt sur eller svagt basisk organisk foerening.
NO163230C (no) Fenol-, formaldehyd- og ureksondensat samt fremstilling og anvendelse derav.
DK155583A (da) Hydantoiner, deres fremstilling og anvendelse
FI842406L (fi) Laongverkande kefaklorformulation.
IT1164254B (it) 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione
NL189071C (nl) Cosmetisch preparaat.
FI850517A7 (fi) Valulaite ja -menetelmä.
FI840451A7 (fi) Liimoitusmenetelmä ja -laite.
FI854257A7 (fi) Suun kautta annettavat rokotteet.
NO155992C (no) Haarpleieapparat.
FI842459A7 (fi) Tetrahydropyridatsinonijohdannaisia, menetelmiä niiden valmistamiseksi sekä niiden käyttö.
NO821159L (no) 2-piperazinopyrimidin og deres fremstilling.
DK162804C (da) Dinitroanilinpraeparat samt dettes fremstilling
FI843500A7 (fi) Eristevalmiste ja menetelmä sen valmistamiseksi.
IT8422159A0 (it) 16-fluoro-16,17-dideidro prostanoidi e procedimento per laloro preparazione.
DK514382A (da) Azolylvinyldithioacetaler, deres fremstilling og anvendelse
FI821671A7 (fi) Jauhamismenetelmä.
FI875399A0 (fi) Videobandspelare med en andra videosignalbana.
FI842616A0 (fi) Foerfarande foer framstaellning av en ny kamomillsort.
DK162979C (da) Polyfluoralkylestere, deres fremstilling og anvendelse
IT8319872A0 (it) 3-(3-idrossibutossi)-1-butanolo esuo metodo di preparazione.
FI862607A7 (fi) Rokote ja menetelmä sen valmistamiseksi.
IT8220039A0 (it) 3-(3-idrossibutossi)-1-butanolo esuo metodo di preparazione.
FI843018A7 (fi) Ehkäisymenetelmiä.
FI833511A7 (fi) Nimeöimislaite ja -menetelmä.

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 39

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 39, 19920302; ISTITUTO LUSO FARMACO D ITALIA SPA

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970529